Phase 1 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able and willing to sign a consent form and follow the study's requirements
- People who are 18 years of age or older at the time of screening
- People who have a solid tumour that has spread or is locally advanced, and has not responded to standard treatments or for which no effective standard treatment exists — preferred cancer types include skin cancer, melanoma, Merkel cell carcinoma, breast cancer, head and neck squamous cell carcinoma, sarcoma, cervical cancer, and colorectal cancer
- People who are in generally good physical condition, rated 0 or 1 on the ECOG scale (meaning fully active or able to carry out light activity, but not requiring significant rest during the day)
Who may not be able to join:
- People who still have significant side effects from previous cancer treatments that have not settled down to mild or no symptoms
- People who are taking corticosteroids (such as prednisone) at a dose higher than 10 mg per day, or an equivalent dose of a similar medicine
- People who currently have an active infection that requires treatment with systemic (whole-body) medicines
- People with certain heart problems, including severe heart failure, uncontrolled high blood pressure, a heart attack or related event within the past 6 months, a significant heart rhythm problem, or an abnormal result on a specific heart electrical reading (QTc interval above 480 ms)
- People with a history of a condition called interstitial lung disease (scarring or inflammation of the lungs)
- People with a history of a blood clotting disorder that causes uncontrolled bleeding or other bleeding problems
- People who have taken part in another clinical trial of an experimental treatment within the past 30 days before screening
- People who, in the opinion of the study doctor, have psychiatric conditions, substance use disorders, or other issues that may prevent them from following the study's requirements
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 020-34070412
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety; Recommended Phase 2 Dose (RP2D); tolerability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.